Cargando…
TRIP11-PDGFRB fusion in a patient with a therapy-related myeloid neoplasm with t(5;14)(q33;q32) after treatment for acute promyelocytic leukemia
BACKGROUND: Therapy-related myeloid neoplasm after treatment for acute promyelocytic leukemia (APL) is a relatively infrequent but severe complication. Most therapy-related myeloid neoplasms after treatment for APL are classified as therapy-related myelodysplastic syndrome or therapy-related acute m...
Autores principales: | Kim, Hoon-Gu, Jang, Ja-Hyun, Koh, Eun-Ha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4299380/ https://www.ncbi.nlm.nih.gov/pubmed/25606057 http://dx.doi.org/10.1186/s13039-014-0103-6 |
Ejemplares similares
-
Myeloid/Lymphoid Neoplasm with PDGFRB Rearrangement with t(5;10)(q33;q22) Harboring a Novel Breakpoint of the CCDC6-PDGFRB Fusion Gene
por: Yamazaki, Miki, et al.
Publicado: (2019) -
Multiple MYO18A-PDGFRB fusion transcripts in a myeloproliferative neoplasm patient with t(5;17)(q32;q11)
por: Sheng, Guangying, et al.
Publicado: (2017) -
A 26-Year-Old Female with Systemic Mastocytosis with Associated Myeloid Neoplasm with Eosinophilia and Abnormalities of PDGFRB, t(4;5)(q21;q33)
por: Brown, Laura E., et al.
Publicado: (2016) -
Genomic and clinical findings in myeloid neoplasms with PDGFRB rearrangement
por: Di Giacomo, Danika, et al.
Publicado: (2021) -
5.14 The Biophysics of Membrane Fusion
por: Collins, R.N., et al.
Publicado: (2012)